Hisham AlJamal

Dr. Hisham AlJamal

orcid
Doctor of Medicine, Orthopaedic Consultant

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Rare Tumors
Verified
Journal Article
Open access
PDF file
ZMZiyad M Mohaidat
Ziyad M Mohaidat
Hisham AlJamalHisham AlJamal
Hisham AlJamal
ABAudai M Bany-Khalaf
Audai M Bany-Khalaf
ARAhmad M Radaideh
Ahmad M Radaideh
ZAZiad Audat
Ziad Audat
Giant cell tumor of bone is a benign tumor with an aggressive behavior. Its typical subarticular location and high recurrence risk can be associated with significant morbidity. Although benign, it can rarely metastasize especially to the lungs. Also, it can be multicentric in less than 1% of patients. Late malignant transformation, although rare, can occur with a very poor prognosis. This series reports on these unusual and challenging features and management considerations of giant cell tumor of bone. This retrospective study included review of the medical records of patients with a confirmed histopathological diagnosis of giant cell tumor of bone. A total of 25 patients (16 females and 9 males) with a mean age of 34.5 years were included; 22 had primary tumors, while 3 were referred with recurrent tumors. Pain was the most common presenting symptom. Most patients had grade III tumors. Tumors around the knee were the most common. Multicentric tumors were detected in three patients. Twenty-three patients (20 primary giant cell tumor of bone and 3 with recurrence) received treatment. Most patients (15/23) were treated with intralesional curettage with or without adjuvants. Seven patients had wide excision. Recurrence was seen in 45% (9/20) of primary giant cell tumor of bone especially with difficult anatomical locations. Most recurrences occurred more than 4 years after treatment. Pulmonary nodules were detected in four patients; two of them showed resolution during follow-up. One patient developed secondary sarcoma transformation with a fatal outcome. Giant cell tumor of bone was more common in females. Long bones were more affected, especially around the knee. Intralesional curettage was the most frequently used treatment. Recurrence was associated with inadequate tumor resection (especially in difficult anatomical location), younger age, male gender, and advanced local tumor grade. Denosumab can be used in the treatment of pulmonary metastasis, multicentric and recurrent giant cell tumor of bone. Due to late recurrence and malignant transformation, a prolonged follow-up is warranted.

2 June 2025 in Pharmacy
Verified
Journal Article
Open access
PDF file
Bayan Faisal AbabnehBayan Faisal Ababneh
Bayan Faisal Ababneh
Hisham AlJamalHisham AlJamal
Hisham AlJamal
Rabia HussainRabia Hussain
Rabia Hussain
Background: Self-medication is the use of medicinal products to treat self-diagnosed disorders or symptoms without the prescription or supervision of a healthcare professional. There is a lack of data about self-medication knowledge, attitudes, and practices among pharmacy undergraduates in Malaysia. This study assessed the knowledge, attitudes, and practices among undergraduate pharmacy students in Penang regarding self-medication. Method: A descriptive cross-sectional study was conducted using a self-administered, web-based survey (Google Forms), which was completed and responded to by 203 undergraduate pharmacy students from Penang, Malaysia, between October and December 2023. Descriptive statistics were used to summarize the socio-demographic characteristics of the participants. Associations between the socio-demographic characteristics of the participants and the knowledge, attitudes, and practices regarding self-medication were assessed using a chi-square test. Regression analyses were carried out to determine whether the socio-demographic characteristics of the participants were associated with practices of self-medication. Results: A total of 203 of the undergraduate pharmacy students completed the questionnaire. More than half of the participants’ age ranged between 19 and 21 years old, the majority were females (77.3%), and 31.5% of the participants had family members employed in the healthcare sector. Most respondents showed good knowledge in a variety of domains: 97.5% acknowledged the potential for drug interaction with other medications, indicating a high awareness of proper self-medication practices. A positive attitude was found regarding participants’ attitudes toward self-medication, and 65.5% practiced self-medication, primarily for treating minor illnesses (75.9%). Common conditions included fever (83.3%), cough/cold/flu (76.8%), and headache (71.4%). Reasons for not self-medicating included the absence of illness (20.2%), lack of knowledge/prior experience (19.2%), and fear of using the wrong medication (18.7%). Only academic year level was the predictor of practicing self-medication within the last six months among the participants. Conclusions: Generally, the participants possessed good knowledge and positive attitudes toward self-medication. The study revealed no significant associations between demographic characteristics and knowledge or attitudes. Insights from this research contribute to understanding self-medication practices among pharmacy students in Penang, informing potential interventions to promote responsible self-medication practices.

3 March 2022 in Clinics in Orthopedic Surgery
Verified
Journal Article
Open access
PDF file
ZAZiad Audat
Ziad Audat
Khalid A. KheirallahKhalid A. Kheirallah
Khalid A. Kheirallah
Bayan Faisal AbabnehBayan Faisal Ababneh
Bayan Faisal Ababneh
Hisham AlJamalHisham AlJamal
Hisham AlJamal
JAJomana Waleed Alsulaiman
Jomana Waleed Alsulaiman
ZAZiad Audat
Ziad Audat
Audat ZA, et al. Clin Orthop Surg. 2022 Mar;14:e11. https://doi.org/10.4055/cios20219

21 January 2024 in Journal of Pharmaceutical Policy and Practice
Verified
Journal Article
Open access
Bayan Faisal AbabnehBayan Faisal Ababneh
Bayan Faisal Ababneh
SOSiew Chin Ong
Siew Chin Ong
IEIffat Elbarazi
Iffat Elbarazi
Hisham AlJamalHisham AlJamal
Hisham AlJamal
Rabia HussainRabia Hussain
Rabia Hussain
Drive-thru services are not given sufficient focus in the community pharmacy setting which was highlighted during COVID-19, particularly in Malaysia. This study aimed to explore the community pharmacists’ perspectives regarding drive-thru community pharmacy service during COVID-19 in Malaysia. In-depth online semi-structured individual interviews were conducted among 25 community pharmacists working in Malaysia. All interviews were conducted between March 2022 and May 2022 and were audio-recorded and transcribed verbatim, and then analysed by thematic analysis. Thematic analysis yielded seven major themes, 1-familiarity with drive-thru community pharmacy service during COVID-19, 2-willingness toward this service during COVID-19, 3-perceived benefits toward drive-thru community pharmacy service during COVID-19, 4-perceived disadvantages toward this service, 5-barriers toward drive-thru community pharmacy service, 6-factors affecting the preference toward this service, and 7-facilitators to drive-thru community pharmacy service. Enhancing social distancing and preventing the spread of COVID-19 were the major perceived benefits of this service during COVID-19 as reported by participants. Overall, community pharmacists reported positive attitudes toward drive-thru community pharmacy service during COVID-19. However, concerns about poor communication between the pharmacist and the patient, limited counselling, and dispensing errors were acknowledged. These concerns would need to be addressed to improve the provision of drive-thru community pharmacy service.

23 October 2026 in Pharmacy
Verified
Journal Article
Open access
PDF file
Bayan Faisal AbabnehBayan Faisal Ababneh
Bayan Faisal Ababneh
Hisham AlJamalHisham AlJamal
Hisham AlJamal
NANour Aymn Ahmad
Nour Aymn Ahmad
LALouai Alsaloumi
Louai Alsaloumi
Background/Objectives: Telepharmacy refers to the use of telecommunication and digital technologies to provide pharmacy services remotely. Early telepharmacy models were implemented in the early 2000s to extend pharmaceutical care to patients in remote and underserved areas. Evaluating pharmacists’ attitudes, awareness, and perceptions of telepharmacy services is essential to inform policy, training, and implementation guidelines. This review summarizes studies on pharmacists’ attitudes, awareness, or perceptions of telepharmacy services. Methods: A systematic literature search was conducted to identify qualitative and descriptive quantitative studies that reported on the attitudes, awareness, or perceptions of pharmacists toward the practice of telepharmacy services from January 2000 through April 2026. Searches were conducted in PubMed/MEDLINE, Scopus, Web of Science, Embase, and Google Scholar. The review was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis PRISMA guidelines. Results: Eighteen studies met the inclusion criteria, comprising 13 cross-sectional quantitative studies and 5 qualitative studies across 11 countries. Overall, the included studies reported generally favorable attitudes and perceptions toward telepharmacy, although awareness varied across studies and settings. Pharmacists perceived telepharmacy as beneficial for healthcare accessibility, patient counseling, medication management, and continuity of care. Reported barriers included inadequate technological infrastructure, insufficient training, increased workload, reimbursement concerns, and absence of standardized regulations or practice guidelines. Common facilitators included professional education and training, institutional support, interprofessional collaboration, improved technological infrastructure, and clear telepharmacy guidelines. Conclusions: Pharmacists generally reported favorable attitudes and perceptions toward telepharmacy, although awareness and experiences varied across healthcare settings and countries. Addressing technological, educational, organizational, financial, and regulatory barriers may support effective and sustainable integration of telepharmacy into pharmacy practice.